Compound Detail
CHEMBL395091
ESKETAMINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL395091 |
| Name | ESKETAMINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | YQEZLKZALYSWHR-ZDUSSCGKSA-N |
| Therapeutic | ✓ Yes |
3
Targets
8
Activities
2
Assay Types
1
PK Parameters
20
Publications
12
Known Names
11
Indications
1
Mechanisms
Molecular Properties
237.7
MW (Da)
2.90
ALogP
2
HBA
1
HBD
29.1
PSA (Ų)
0.86
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2019 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Glutamate [NMDA] receptor negative allosteric modulator | NEGATIVE ALLOSTERIC MODULATOR | Glutamate [NMDA] receptor | ✓ | ✓ |
Indications
Depressive Disorder Depressive Disorder Depressive Disorder, Treatment-Resistant Pain Shock, Septic Cancer Pain Kidney Diseases Liver Diseases Rhinitis, Allergic, Seasonal Substance-Related Disorders Delirium
ATC Classification
N01AX14
esketamine
Level 1: NERVOUS SYSTEM
Level 2: ANESTHETICS
N06AX27
esketamine
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOANALEPTICS
Activity Summary
Ki 6 meas. best 6.97
IC50 2 meas. best 7.94
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Glutamate NMDA receptor; GRIN1/GRIN2A CHEMBL1907604 | IC50 | 7.94 | 7.94 | 11.4 | 1 |
| Unchecked CHEMBL612545 | Ki | 6.97 | 6.59 | 108.0 | 3 |
| Glutamate NMDA receptor CHEMBL1907608 | Ki | 6.52 | 6.2333 | 300.0 | 3 |
| Glutamate NMDA receptor CHEMBL1907608 | IC50 | 6.19 | 6.19 | 640.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| Cmax | 7.33 | umol/Kg | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 26296478 | 10.1016/j.bmcl.2015.08.017 | Glutamate NMDA receptor | 15 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 3 |
| 30996788 | 10.1021/acsmedchemlett.8b00536 | MCF7 | 3 |
| 30996788 | 10.1021/acsmedchemlett.8b00536 | SK-BR-3 | 3 |
| 19345586 | 10.1016/j.bmc.2009.03.025 | Glutamate NMDA receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Androgen receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 2 |
| 32915563 | 10.1021/acs.jmedchem.0c01193 | Glutamate NMDA receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Voltage-dependent L-type calcium channel subunit alpha-1C | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Glutamate receptor ionotropic, NMDA 1 | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-1 adrenergic receptor | 1 |
| 37468498 | 10.1038/s41467-023-40064-9 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 26430967 | 10.1021/acs.jmedchem.5b01214 | Glutamate NMDA receptor; GRIN1/GRIN2A | 1 |
| 26430967 | 10.1021/acs.jmedchem.5b01214 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine